Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
106,851,987
-
Total 13F shares
-
68,456,122
-
Share change
-
+1,578,607
-
Total reported value
-
$478,728,444
-
Price per share
-
$6.99
-
Number of holders
-
95
-
Value change
-
-$147,649
-
Number of buys
-
49
-
Number of sells
-
51
Institutional Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q1 2022
As of 31 Mar 2022,
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,456,122 shares.
The largest 10 holders included
Casdin Capital, LLC, BlackRock Inc., BAMCO INC /NY/, Vitruvian Partners LLP, D1 Capital Partners L.P., VANGUARD GROUP INC, Holocene Advisors, LP, RIVER & MERCANTILE ASSET MANAGEMENT LLP, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and AMERICAN CENTURY COMPANIES INC.
This page lists
95
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.